Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Gerontol A Biol Sci Med Sci ; 70(7): 800-8, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25123646

ABSTRACT

Heat shock proteins (HSPs) are molecular chaperones with roles in longevity and muscular preservation. We aimed to show elevating HSP70 improves indices of health span. Aged C57/BL6 mice acclimated to a western diet were randomized into: geranylgeranylacetone (GGA)-treated (100 mg/kg/d), biweekly heat therapy (HT), or control. The GGA and HT are well-known pharmacological and environmental inducers of HSP70, respectively. Assessments before and after 8 weeks of treatment included glycemic endpoints, body composition, and muscular endurance, power, and perfusion. An HT mice had more than threefold, and GGA mice had a twofold greater HSP70 compared with control. Despite comparable body compositions, both treatment groups had significantly better insulin sensitivity and insulin signaling capacity. Compared with baseline, HT mice ran 23% longer than at study start, which was significantly more than GGA or control. Hanging ability (muscular endurance) also tended to be best preserved in HT mice. Muscle power, contractile force, capillary perfusion, and innervation were not different. Heat treatment has a clear benefit on muscular endurance, whereas HT and GGA both improved insulin sensitivity. Different effects may relate to muscle HSP70 levels. An HSP induction could be a promising approach for improving health span in the aged mice.


Subject(s)
HSP70 Heat-Shock Proteins/physiology , Insulin Resistance/physiology , Muscle Strength/physiology , Muscle, Skeletal/physiology , Physical Endurance/physiology , Animals , Body Composition , Diterpenes , Female , Hyperthermia, Induced , Mice , Mice, Inbred C57BL , Random Allocation
2.
Comp Med ; 64(3): 221-3, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24956214

ABSTRACT

Selective serotonin reuptake inhibitors (SSRI) are associated with an increased bleeding risk in humans. This report describes a bleeding event in a cynomolgus macaque (Macaca fascicularis) treated with the SSRI sertraline HCl (Zoloft). During the treatment course, the subject presented with a maculopapular rash, cutaneous bleeding, epistaxis, bleeding from the eye, melena, and a severe thrombocytopenia. To our knowledge, this report is the first description of an SSRI-related adverse event in a nonhuman primate. This report demonstrates that the clinical presentation of SSRI-associated bleeding in cynomolgus macaques is consistent with that reported in humans and that complications from SSRI treatment should be considered as a differential diagnosis for maculopapular dermatitis or spontaneous bleeding in this species.


Subject(s)
Animals, Laboratory , Hemorrhage/veterinary , Macaca fascicularis , Monkey Diseases/chemically induced , Monkey Diseases/pathology , Selective Serotonin Reuptake Inhibitors/adverse effects , Sertraline/adverse effects , Animals , Depression/drug therapy , Hemorrhage/chemically induced , Hemorrhage/pathology , Thrombocytopenia/chemically induced , Thrombocytopenia/pathology
3.
Menopause ; 21(10): 1136-42, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24618766

ABSTRACT

OBJECTIVE: Soy isoflavones are commonly used to alleviate menopause-related symptoms. Postmenopausal women are at increased risk for hypothyroidism, and there are concerns that isoflavones may be detrimental to thyroid health. The aim of this study was to examine the effects of soy protein and isoflavones on thyroid function and the relationship between thyroid function and ovarian function. METHODS: Adult female cynomolgus monkeys (Macaca fascicularis) were randomized to consume two diets differing only in protein source: casein-lactalbumin (n = 44) or soy protein with isoflavones (n = 41). After 34 months, all animals were ovariectomized via laparotomy. Half of the monkeys from each diet treatment group continued to consume their preovariectomy treatment phase diet (either isolated soy protein [n = 19] or casein-lactalbumin [n = 21]) for an additional 34 months. The remaining animals did not continue their diets and thus were not considered further. Circulating progesterone, triiodothyronine, thyroxine, and thyroid-stimulating hormone were measured at baseline. Thyroid hormones were remeasured during each treatment phase. RESULTS: Dietary soy increased triiodothyronine in preovariectomized monkeys and prevented a decline in thyroxine after surgical menopause (both P's < 0.05). Mean progesterone concentrations were positively correlated with triiodothyronine at baseline in preovariectomized monkeys (P < 0.01). CONCLUSIONS: Progesterone levels and triiodothyronine are positively correlated in macaques. Dietary soy increases triiodothyronine in preovariectomized monkeys and prevents a decline in thyroxine after surgical menopause. The outcomes observed in this study suggest that soy protein and isoflavone consumption does not adversely affect-and may even preserve-thyroid function in postmenopausal women.


Subject(s)
Glycine max/chemistry , Isoflavones/pharmacology , Macaca fascicularis/blood , Ovariectomy/veterinary , Soybean Proteins/pharmacology , Thyroid Hormones/blood , Animals , Caseins/administration & dosage , Dietary Proteins/administration & dosage , Female , Isoflavones/adverse effects , Lactalbumin/administration & dosage , Ovary/physiology , Progesterone/blood , Thyroid Gland/drug effects , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...